Exosomal miR-214-5p Released from Glioblastoma Cells Modulates Inflammatory Response of Microglia after

Jian-Kai Yang1, Hong-Jiang Liu1, Yuanyu Wang1

  • 1Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China.

Abstract

Insights

Exosomal miR-214-5p is overexpressed in glioblastoma (GBM) and drives tumor progression by promoting cell proliferation and migration. This microRNA also modulates the inflammatory response in microglia, highlighting its role in the GBM microenvironment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Exosomes mediate intercellular communication, with microRNAs (miRNAs) playing key roles.
  • MiR-214-5p has diverse functions in various tumors, but its role in glioblastoma (GBM) via exosomes is unclear.

Purpose of the Study:

  • To investigate the role of exosomal miR-214-5p in the glioblastoma microenvironment.
  • To elucidate the mechanism by which miR-214-5p influences GBM progression and the tumor microenvironment.

Main Methods:

  • Real-time PCR for miR-214-5p expression.
  • MTT and transwell assays for cell viability and migration.
  • ELISA for cytokines, luciferase assay for target validation, and Western blot for protein levels.

Main Results:

  • miR-214-5p was overexpressed in GBM and correlated with poor prognosis.
  • Elevated miR-214-5p enhanced GBM cell proliferation and migration.
  • GBM-derived exosomal miR-214-5p promoted inflammation in microglia, targeting CXCR5.

Conclusions:

  • Overexpression of miR-214-5p in GBM influences the inflammatory response in microglia through exosomal transfer.
  • Exosomal miR-214-5p is a potential therapeutic target for glioblastoma.

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.7K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
7.8K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.7K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
16.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
908
Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin,...
620